Morningstar

Professional Investors
The 60/40 debate: Is it still relevant?
The 60/40 debate: Is it still relevant?
Equity-bond diversification is still a strong strategy for investors.
Visit arrow right black
Professional Investors
A dose of clarity for pharma investors
A dose of clarity for pharma investors
European pharmaceuticals have dodged steep tariff threats.
Visit arrow right black
Professional Investors
Peace talks trigger defence stock slumps
Peace talks trigger defence stock slumps
Is the dip hiding defence’s long-term momentum?
Visit arrow right black
Professional Investors
Will Europe continue to benefit as investors avoid Mag 7?
Will Europe continue to benefit as investors avoid Mag 7?
Where are investors seeking diversification?
Visit arrow right black
Professional Investors
Pharma stocks brace for pricing pressure following Trump ultimatums
Pharma stocks brace for pricing pressure following Trump ultimatums
How will pricing reforms reshape the sector?
Visit arrow right black
Professional Investors
Undervalued stocks in Europe's defence drive
Undervalued stocks in Europe's defence drive
Which equities remain cheap despite the continent’s spending spree?
Visit arrow right black
Professional Investors
Tariff uncertainty boosts gold and copper again
Tariff uncertainty boosts gold and copper again
Which other commodities should investors be targeting in 2025?
Visit arrow right black
Professional Investors
How EU-US trade deal validates recent rally
How EU-US trade deal validates recent rally
What long-term impact will tariffs have on equities?
Visit arrow right black
Professional Investors
Income funds offer steady success
Income funds offer steady success
How can dividend funds reduce risk and boost efficiency?
Visit arrow right black
Professional Investors
Investors dismiss tariff turbulence
Investors dismiss tariff turbulence
Should markets be more mindful of potential trade measures?
Visit arrow right black
Professional Investors
Are luxury stocks back in fashion?
Are luxury stocks back in fashion?
With demand expected to increase next year, brands are well-positioned for a revival.
Visit arrow right black
Professional Investors
ESG funds continue to embrace arms
ESG funds continue to embrace arms
Rising defence exposure has challenged traditional ESG standpoints.
Visit arrow right black
Not a member yet?
Get access to all of the Investment IQ curated content completely free today
IQ logo